Comparative fracture risk amongst users of different anti-osteoporosis therapies: meta-analysis of propensity-matched cohort studies using data from the Clinical Practice Research Datalink (UK) and SIDIAP (Spain).
- Despite the existence of plentiful evidence on the efficacy of anti-osteoporosis drugs (AOD) to prevent fractures in randomized controlled trials, there is a need for data on their comparative effectiveness and safety in actual practice. We aimed to compare the anti-fracture effectiveness of available AODs based on the observed risk of fracture while on treatment using ‘real world’ data from the UK NHS and Spanish healthcare records.
- Publication status:
- Peer review status:
- Reviewed (other)
(Accepted manuscript, pdf, 466.6KB)
- Publisher copy:
- Pubs id:
- Local pid:
- Deposit date:
- Copyright holder:
- Khalid et al
- Copyright date:
- © The Author 2017. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: firstname.lastname@example.org. This is the accepted manuscript version of the article. The final version is available online from Oxford University Press at: http:// dx.doi.org/10.1093/rheumatology/kex061.011
If you are the owner of this record, you can report an update to it here: Report update to this record